These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

993 related articles for article (PubMed ID: 31883794)

  • 21. GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma.
    Gargett T; Ebert LM; Truong NTH; Kollis PM; Sedivakova K; Yu W; Yeo ECF; Wittwer NL; Gliddon BL; Tea MN; Ormsby R; Poonnoose S; Nowicki J; Vittorio O; Ziegler DS; Pitson SM; Brown MP
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36167468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
    Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of patient-derived organoid models of lower-grade glioma.
    Abdullah KG; Bird CE; Buehler JD; Gattie LC; Savani MR; Sternisha AC; Xiao Y; Levitt MM; Hicks WH; Li W; Ramirez DMO; Patel T; Garzon-Muvdi T; Barnett S; Zhang G; Ashley DM; Hatanpaa KJ; Richardson TE; McBrayer SK
    Neuro Oncol; 2022 Apr; 24(4):612-623. PubMed ID: 34850183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glioblastoma and cerebral organoids: development and analysis of an in vitro model for glioblastoma migration.
    Fedorova V; Pospisilova V; Vanova T; Amruz Cerna K; Abaffy P; Sedmik J; Raska J; Vochyanova S; Matusova Z; Houserova J; Valihrach L; Hodny Z; Bohaciakova D
    Mol Oncol; 2023 Apr; 17(4):647-663. PubMed ID: 36744875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetically engineered cerebral organoids model brain tumor formation.
    Bian S; Repic M; Guo Z; Kavirayani A; Burkard T; Bagley JA; Krauditsch C; Knoblich JA
    Nat Methods; 2018 Aug; 15(8):631-639. PubMed ID: 30038414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintaining Human Glioblastoma Cellular Diversity Ex vivo using Three-Dimensional Organoid Culture.
    Sundar SJ; Shakya S; Recinos V; Hubert CG
    J Vis Exp; 2022 Aug; (186):. PubMed ID: 36094291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of the Cerebral Organoid Glioma 'GLICO' Model for Screening Applications.
    Weth FR; Peng L; Paterson E; Tan ST; Gray C
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
    Maru Y; Tanaka N; Itami M; Hippo Y
    Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor organoid biobank-new platform for medical research.
    Xie X; Li X; Song W
    Sci Rep; 2023 Feb; 13(1):1819. PubMed ID: 36725963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments.
    Lago C; Federico A; Leva G; Mack NL; Schwalm B; Ballabio C; Gianesello M; Abballe L; Giovannoni I; Reddel S; Rossi S; Leone N; Carai A; Mastronuzzi A; Bisio A; Soldano A; Quintarelli C; Locatelli F; Kool M; Miele E; Tiberi L
    EMBO Mol Med; 2023 Dec; 15(12):e18199. PubMed ID: 38037472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.
    Lee SH; Hu W; Matulay JT; Silva MV; Owczarek TB; Kim K; Chua CW; Barlow LJ; Kandoth C; Williams AB; Bergren SK; Pietzak EJ; Anderson CB; Benson MC; Coleman JA; Taylor BS; Abate-Shen C; McKiernan JM; Al-Ahmadie H; Solit DB; Shen MM
    Cell; 2018 Apr; 173(2):515-528.e17. PubMed ID: 29625057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined antitumor effects of anti-EGFR variant III CAR-T cell therapy and PD-1 checkpoint blockade on glioblastoma in mouse model.
    Song Y; Liu Q; Zuo T; Wei G; Jiao S
    Cell Immunol; 2020 Jun; 352():104112. PubMed ID: 32305131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes.
    Xie Y; Bergström T; Jiang Y; Johansson P; Marinescu VD; Lindberg N; Segerman A; Wicher G; Niklasson M; Baskaran S; Sreedharan S; Everlien I; Kastemar M; Hermansson A; Elfineh L; Libard S; Holland EC; Hesselager G; Alafuzoff I; Westermark B; Nelander S; Forsberg-Nilsson K; Uhrbom L
    EBioMedicine; 2015 Oct; 2(10):1351-63. PubMed ID: 26629530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening.
    Choi SY; Shim J; Gu DE; Kim SY; Kim HJ; Shin DY; Chung MK
    Oral Oncol; 2023 Nov; 146():106571. PubMed ID: 37741019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR-T cells
    Yu L; Li Z; Mei H; Li W; Chen D; Liu L; Zhang Z; Sun Y; Song F; Chen W; Huang W
    Clin Transl Immunology; 2021; 10(2):e1248. PubMed ID: 33552510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screening.
    Jiguet Jiglaire C; Baeza-Kallee N; Denicolaï E; Barets D; Metellus P; Padovani L; Chinot O; Figarella-Branger D; Fernandez C
    Exp Cell Res; 2014 Feb; 321(2):99-108. PubMed ID: 24355810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications of organoid technology to brain tumors.
    Wen J; Liu F; Cheng Q; Weygant N; Liang X; Fan F; Li C; Zhang L; Liu Z
    CNS Neurosci Ther; 2023 Oct; 29(10):2725-2743. PubMed ID: 37248629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology.
    Xu X; Kumari R; Zhou J; Chen J; Mao B; Wang J; Zheng M; Tu X; An X; Chen X; Zhang L; Tian X; Wang H; Dong X; Bao Z; Guo S; Ouyang X; Shang L; Wang F; Yan X; Zhang R; Vries RGJ; Clevers H; Li QX
    PLoS One; 2023; 18(1):e0279821. PubMed ID: 36602988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Patient-Derived Xenograft Model of Glioblastoma.
    Chokshi CR; Savage N; Venugopal C; Singh SK
    STAR Protoc; 2020 Dec; 1(3):100179. PubMed ID: 33377073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.